These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 17940368)

  • 1. [Lung cancer].
    Tsuboi M; Kato H
    Gan To Kagaku Ryoho; 2007 Oct; 34(10):1538-42. PubMed ID: 17940368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival improvement in resectable non-small cell lung cancer with (neo)adjuvant chemotherapy: results of a meta-analysis of the literature.
    Berghmans T; Paesmans M; Meert AP; Mascaux C; Lothaire P; Lafitte JJ; Sculier JP
    Lung Cancer; 2005 Jul; 49(1):13-23. PubMed ID: 15949586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances in our understanding of postoperative adjuvant chemotherapy in resectable non-small-cell lung cancer.
    Hotta K; Matsuo K; Kiura K; Ueoka H; Tanimoto M
    Curr Opin Oncol; 2006 Mar; 18(2):144-50. PubMed ID: 16462183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of adjuvant chemotherapy in patients with resected non-small-cell lung cancer: reappraisal with a meta-analysis of randomized controlled trials.
    Hotta K; Matsuo K; Ueoka H; Kiura K; Tabata M; Tanimoto M
    J Clin Oncol; 2004 Oct; 22(19):3860-7. PubMed ID: 15326194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of surgery in N2 non-small cell lung cancer.
    DeCamp MM; Ashiku S; Thurer R
    Clin Cancer Res; 2005 Jul; 11(13 Pt 2):5033s-5037s. PubMed ID: 16000610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resected non-small-cell lung cancer stage I/II: indication for adjuvant/neoadjuvant therapy?
    Hoffmann H
    Lung Cancer; 2004 Aug; 45 Suppl 2():S91-7. PubMed ID: 15552788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Magnitude of benefit of adjuvant chemotherapy for non-small cell lung cancer: meta-analysis of randomized clinical trials.
    Bria E; Gralla RJ; Raftopoulos H; Cuppone F; Milella M; Sperduti I; Carlini P; Terzoli E; Cognetti F; Giannarelli D
    Lung Cancer; 2009 Jan; 63(1):50-7. PubMed ID: 18565615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Non-small cell lung cancer (NSCLC): the evolution of neo-adjuvant chemotherapy in the last 15 years].
    Santo A; Genestreti G; Fiorio E; Terzi A; Lonardoni A; Calabrò F; Campaldini B; Colaluca P; Molino A; Cetto GL
    Recenti Prog Med; 2006 Apr; 97(4):211-8. PubMed ID: 16729492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overview of the randomized phase III trials in non-small cell lung cancer in North America.
    Kelly K
    Semin Oncol; 1997 Jun; 24(3 Suppl 8):S8-2-S8-5. PubMed ID: 9207308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-small cell lung cancer: adjuvant and neo-adjuvant chemotherapy.
    Brahmer JR; Ettinger DS
    Respirology; 2007 May; 12(3):320-5. PubMed ID: 17539833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of preoperative chemotherapy for non-small-cell lung cancer: a meta-analysis.
    Nakamura H; Kawasaki N; Taguchi M; Kabasawa K
    Lung Cancer; 2006 Dec; 54(3):325-9. PubMed ID: 16987564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Early stages of non small cell lung cancer (I. II. IIIA). What is the best therapeutic strategy?].
    Riquet M; Berna P
    Rev Mal Respir; 2006 Nov; 23(5 Pt 3):16S36-16S42. PubMed ID: 17268334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Which treatments should be proposed in resectable stage III cancers?].
    Thibout Y; Cortot A; Chapet O; Mornex F; Milleron B
    Rev Pneumol Clin; 2004 Nov; 60(5 Pt 2):3S37-42. PubMed ID: 15536351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjuvant chemotherapy for non-small cell lung cancer.
    Solomon B; Bunn PA
    Cancer Invest; 2007 Jun; 25(4):217-25. PubMed ID: 17612931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Adjuvant chemotherapy for resectable non-small cell lung cancer (NSCLC)].
    Nakajima E; Katou H
    Kyobu Geka; 2008 Jan; 61(1):4-8. PubMed ID: 18186265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Improved prognosis in non small cell lung cancer--myth or reality?].
    Milleron B; Lavolé A; Gounant V
    Rev Mal Respir; 2005 Dec; 22(6 Pt 2):8S137-42. PubMed ID: 16340850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lung cancer adjuvant therapy.
    Horn L; Sandler A
    Cancer J; 2007; 13(3):210-6. PubMed ID: 17620772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccines for the treatment of non-small cell lung cancer: a renewed anticancer strategy.
    Gridelli C; Rossi A; Maione P; Ferrara ML; Castaldo V; Sacco PC
    Oncologist; 2009 Sep; 14(9):909-20. PubMed ID: 19726457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stage IIIA-N2 NSCLC: a review of its treatment approaches and future developments.
    van Meerbeeck JP; Surmont VF
    Lung Cancer; 2009 Sep; 65(3):257-67. PubMed ID: 19285751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neoadjuvant versus adjuvant therapy for resectable non-small-cell lung cancer.
    Belani CP
    Clin Lung Cancer; 2004 Jul; 6(1):8. PubMed ID: 15310410
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.